Findings suggest that cancer survivors have a significantly higher prevalence of both audiometry-confirmed and self-reported hearing loss than the general population.
Depression Affects Two-Year Survival Rates in Head and Neck Cancer Patients
Depression at time of treatment planning appeared to be as important a predictor of two-year survival as traditional clinical prognostic indicators.
Survivors of Head and Neck Cancers Experience Long-Lasting Cognitive Deficits
Survivors of head and neck cancers are at risk for delayed neurocognitive deficits for at least two years following radiotherapy or chemotherapy